Sort content by
Harvard 2019

Healthcare’s multiple opportunities

William Haseltine had a long career at Harvard Medical School, educating a generation of doctors, and designing the strategy to develop the first treatment for HIV/AIDS. He addressed the Fiduciary Investors Symposium about important topics in medicine and health development.
Harvard 2014

The biggest risk for investors is misunderstanding uncertainty

As the focus of retirees shifts ever-further towards objectives-based outcomes, those entrusted with achieving those objectives will have to rethink a traditional approach to managing money involving risk and return trade-offs. Speaking at the Fiduciary Investors Symposium (FIS) at Harvard University, Abdallah Nauphal, chief executive and chief investment officer of Insight Investment, a BNY Mellon […]
Harvard 2014

Good for Harvard, good for the world: Why HMC embraced ESG with a passion

Harvard Management Corporation (HMC) signed up to the UN-supported Principles for Responsible Investment (PRI) less than a year ago, but the company that manages the $36 billion Harvard University endowment is already moving rapidly to build environmental, social and governance (ESG) factors into every investment decision it makes. Jane Mendillo, president and chief executive of […]
Harvard 2014

G20 urged to develop policies to support long-term investment

The Fiduciary Investors Symposium (FIS) at Harvard University has identified several of the key barriers to pension funds, endowments and sovereign wealth funds adopting more effective long-term and sustainable investment strategies, and is preparing a communiqué to the upcoming meeting of the G20 to convey its concerns and its policy requirements. FIS, organised and hosted […]
<1of2>